Chief Medical Officer · GILEAD SCIENCES, INC. · GILEAD SCIENCES, INC. — Restricted Stock Unit
Side
M
Value
—
Shares
533
Price
—
Executed
Sep 10, 2026
Disclosed
Sep 11, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Sep 10 executedSep 11, 2026 disclosed
GILD · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+1 / 25
No reported dollar value · 1.2% of prior position
Filing timing0 / 15
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Berger Dietmar filed this Form 4 reporting a option exercise of GILD on Sep 10, 2026. It became public on Sep 11, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Medical Officer
Berger Dietmarcik:0001739515
Issuer
GILEAD SCIENCES, INC.cik:0000882095
Revision history · 0
No field has changed since this record was first ingested.
